The study was performed in a group of 112 patients with APS and healthy subjects to assess the distribution of HLA-DRB1 alleles in patients with APS and their association with clinical characteristics of patients with APS—antiphospholipid antibodies (aPLs) presence and disease activity/damage indexes. Here, HLA-DRB1 is linked to autoimmune polyendocrinopathy.